» Articles » PMID: 37161796

Metabolomic Profiles Associated With Blood Pressure Reduction in Response to the DASH and DASH-Sodium Dietary Interventions

Overview
Journal Hypertension
Date 2023 May 10
PMID 37161796
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The DASH (Dietary Approaches to Stop Hypertension) diets reduced blood pressure (BP) in the DASH and DASH-Sodium trials, but the underlying mechanisms are unclear. We identified metabolites associated with systolic BP or diastolic BP (DBP) changes induced by dietary interventions (DASH versus control arms) in 2 randomized controlled feeding studies-the DASH and DASH-Sodium trials.

Methods: Metabolomic profiling was conducted in serum and urine samples collected at the end of diet interventions: DASH (n=219) and DASH-Sodium (n=395). Using multivariable linear regression models, associations were examined between metabolites and change in systolic BP and DBP. Tested for interactions between diet interventions and metabolites were the following comparisons: (1) DASH versus control diets in the DASH trial (serum), (2) DASH high-sodium versus control high-sodium diets in the DASH-Sodium trial (urine), and (3) DASH low-sodium versus control high-sodium diets in the DASH-Sodium trial (urine).

Results: Sixty-five significant interactions were identified (DASH trial [serum], 12; DASH high sodium [urine], 35; DASH low sodium [urine], 18) between metabolites and systolic BP or DBP. In the DASH trial, serum tryptophan betaine was associated with reductions in DBP in participants consuming the DASH diets but not control diets ( interaction, 0.023). In the DASH-Sodium trial, urine levels of N-methylglutamate and proline derivatives (eg, stachydrine, 3-hydroxystachydrine, N-methylproline, and N-methylhydroxyproline) were associated with reductions in systolic BP or DBP in participants consuming the DASH diets but not control diets ( interaction, <0.05 for all tests).

Conclusions: We identified metabolites that were associated with BP lowering in response to dietary interventions.

Registration: URL: https://www.

Clinicaltrials: gov/ct2/show/NCT00000608; Unique identifier: NCT00000608 (DASH-Sodium trial).

Citing Articles

Nutrition and Hypertension Researches in 2023: focus on salt intake and blood pressure.

Matsumoto C Hypertens Res. 2025; .

PMID: 39871003 DOI: 10.1038/s41440-024-02089-5.


A Metabolome Wide Association Study of Fruit and Vegetable Consumption and Associations with Cardiovascular Disease Risk Factors: The International Study of Macro-/Micronutrients and Blood Pressure (INTERMAP) Study.

Oude Griep L, Chekmeneva E, Van Horn L, Chan Q, Daviglus M, Frost G J Nutr. 2024; 155(1):122-131.

PMID: 39536968 PMC: 11795696. DOI: 10.1016/j.tjnut.2024.11.004.


Plant Protein but Not Animal Protein Consumption Is Associated with Frailty through Plasma Metabolites.

Tanaka T, Das J, Jin Y, Tian Q, Moaddel R, Moore A Nutrients. 2023; 15(19).

PMID: 37836476 PMC: 10574762. DOI: 10.3390/nu15194193.

References
1.
DiNicolantonio J, Niazi A, Lavie C, OKeefe J, Ventura H . Thiamine supplementation for the treatment of heart failure: a review of the literature. Congest Heart Fail. 2013; 19(4):214-22. DOI: 10.1111/chf.12037. View

2.
Svetkey L, Sacks F, Obarzanek E, Vollmer W, Appel L, Lin P . The DASH Diet, Sodium Intake and Blood Pressure Trial (DASH-sodium): rationale and design. DASH-Sodium Collaborative Research Group. J Am Diet Assoc. 1999; 99(8 Suppl):S96-104. DOI: 10.1016/s0002-8223(99)00423-x. View

3.
Sumner L, Amberg A, Barrett D, Beale M, Beger R, Daykin C . Proposed minimum reporting standards for chemical analysis Chemical Analysis Working Group (CAWG) Metabolomics Standards Initiative (MSI). Metabolomics. 2013; 3(3):211-221. PMC: 3772505. DOI: 10.1007/s11306-007-0082-2. View

4.
Landberg R, Aman P, Friberg L, Vessby B, Adlercreutz H, Kamal-Eldin A . Dose response of whole-grain biomarkers: alkylresorcinols in human plasma and their metabolites in urine in relation to intake. Am J Clin Nutr. 2008; 89(1):290-6. DOI: 10.3945/ajcn.2008.26709. View

5.
Wang D, Toledo E, Hruby A, Rosner B, Willett W, Sun Q . Plasma Ceramides, Mediterranean Diet, and Incident Cardiovascular Disease in the PREDIMED Trial (Prevención con Dieta Mediterránea). Circulation. 2017; 135(21):2028-2040. PMC: 5496817. DOI: 10.1161/CIRCULATIONAHA.116.024261. View